{"context":{"query":">>hgnc>>gwas","source_dataset":"hgnc","target_dataset":"gwas"},"stats":{"queried":1,"total":51,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"HGNC:7553","source":"HGNC:7553|MYC proto-oncogene, bHLH transcription factor","targets":["GCST000231_2|Urinary bladder cancer|CASC11|8|9.000000e-12","GCST000639_1|Urinary bladder cancer|CASC11|8|7.000000e-12","GCST000802_5|Ovarian cancer|LINC00824|8|3.000000e-09","GCST000842_5|Bladder cancer|CASC11|8|2.000000e-18","GCST001198_62|Multiple sclerosis|PVT1|8|8.000000e-09","GCST001787_1|Colorectal cancer|PCAT1, CASC8, POU5F1B, CCAT2|8|1.000000e-11","GCST001937_34|Breast cancer|PVT1|8|3.000000e-11","GCST001941_3|Ovarian cancer|LINC00824|8|3.000000e-12","GCST002073_17|Chronic lymphocytic leukemia|CASC19, PCAT1|8|2.000000e-08","GCST002084_5|Allergic sensitization|PVT1|8|5.000000e-10","GCST002273_1|Renal cell carcinoma|PVT1; PVT1; PVT1|8;8|5.000000e-11","GCST002411_9|Colorectal cancer|PCAT1, CASC8, POU5F1B|8|8.000000e-13","GCST002413_8|Prostate cancer (early onset)|PCAT1, CASC8, POU5F1B|8|9.000000e-09","GCST002421_6|Prostate cancer|CASC8|8|6.000000e-18","GCST002460_1|Urinary bladder cancer|CASC11|8|2.000000e-07","GCST002553_3|Pancreatic cancer|LINC00824|8|1.000000e-07","GCST002636_5|Diffuse large B cell lymphoma|PVT1|8|1.000000e-12","GCST002636_6|Diffuse large B cell lymphoma|RN7SKP226 - LINC00824|8|4.000000e-11","GCST002702_37|Height|PVT1|8|3.000000e-10","GCST002919_8|Colorectal cancer|CASC8, PCAT1, POU5F1B|8|6.000000e-15","GCST003017_15|Colorectal cancer|PCAT1, CASC8, POU5F1B, CCAT2|8|4.000000e-14","GCST003524_3|Endometrial cancer|LINC00824 - CCDC26|8|3.000000e-09","GCST003524_8|Endometrial cancer|LINC00824|8|4.000000e-07","GCST003525_2|Endometrial endometrioid carcinoma|LINC00824 - CCDC26|8|8.000000e-09","GCST003758_2|Pancreatic cancer|CASC11|8|3.000000e-09","GCST004093_26|Prostate-specific antigen levels|PCAT1, CASC8, POU5F1B|8|7.000000e-21","GCST004094_3|Prostate-specific antigen levels (conditioned on lead SNPs)|CASC8, POU5F1B, PCAT1|8|2.000000e-10","GCST004166_56|Nonsyndromic cleft lip with cleft palate|CCDC26|8|8.000000e-16","GCST004988_564|Breast cancer|PVT1|8|1.000000e-13","GCST005038_17|Allergic disease (asthma, hay fever or eczema)|PVT1|8|6.000000e-14","GCST005434_8|Pancreatic cancer|CASC11|8|1.000000e-09","GCST005931_15|Glioma|CCDC26|8|1.000000e-14","GCST005931_16|Glioma|CCDC26|8|1.000000e-39","GCST005932_11|Glioblastoma|CCDC26|8|4.000000e-07","GCST005933_10|Non-glioblastoma glioma|CCDC26|8|2.000000e-65","GCST005933_9|Non-glioblastoma glioma|CCDC26|8|8.000000e-36","GCST006409_39|Allergic rhinitis|PVT1|8|4.000000e-08","GCST006464_12|Endometrial cancer|LINC00824|8|3.000000e-09","GCST006464_13|Endometrial cancer|LINC00824 - CCDC26|8|8.000000e-14","GCST006465_13|Endometrial cancer (endometrioid histology)|LINC00824 - CCDC26|8|1.000000e-13","GCST007798_112|Asthma|MYC - PVT1|8|2.000000e-11","GCST007800_55|Asthma (childhood onset)|MYC - PVT1|8|1.000000e-23","GCST007856_23|Colorectal cancer or advanced adenoma|CASC8 - CASC11|8|1.000000e-09","GCST007856_6|Colorectal cancer or advanced adenoma|POU5F1B, PCAT1, CASC8|8|2.000000e-56","GCST007856_84|Colorectal cancer or advanced adenoma|PCAT1, CASC8, POU5F1B, CCAT2|8|3.000000e-64","GCST007995_53|Asthma (childhood onset)|MYC - PVT1|8|2.000000e-10","GCST008259_13|Alcohol use disorder|CASC8 - CASC11|8|5.000000e-08","GCST010042_34|Asthma|MYC - PVT1|8|1.000000e-14","GCST010043_160|Asthma|MYC - PVT1|8|3.000000e-15","GCST90011900_78|Serum alkaline phosphatase levels|CCDC26|8|1.000000e-08","GCST90014325_67|Asthma|MYC - PVT1|8|3.000000e-08"]}]}